Journal:Analysis of cannabidiol, delta-9-tetrahydrocannabinol, and their acids in CBD/hemp oil products

From LIMSWiki
Revision as of 18:40, 5 October 2020 by Shawndouglas (talk | contribs) (Created stub. Saving and adding more.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
Full article title Analysis of cannabidiol, Δ9-tetrahydrocannabinol, and their acids in CBD/hemp oil products
Journal Medical Cannabis and Cannabinoids
Author(s) ElSohly, M.A., Murphy, T.P.; Khan, I.; Walker, L.W.; Gul, W.
Author affiliation(s) ElSohly Laboratories, University of Mississippi
Primary contact Email: elsohly at elsohly dot com
Year published 2020
Volume and issue 3(1)
Page(s) 1–13
DOI 10.1159/000509550
ISSN 2504-3889
Distribution license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Website https://www.karger.com/Article/FullText/509550
Download https://www.karger.com/Article/Pdf/509550 (PDF)

Abstract

Hemp products are readily available and are aggressively marketed for their health and medicinal benefits. Most consumers of these products are interested because of their cannabidiol (CBD) content, which has taken the natural products industry by storm. The CBD and Δ9-tetrahydrocannabinol (Δ9-THC) concentrations in these products are often absent, and even where labeled, the accuracy of the label amounts is often questionable. In order to gain a better understanding of the CBD content, fifty hemp products were analyzed by gas chromatography coupled with mass spectrometry (GC-MS) for CBD, Δ9-THC, tetrahydrocannabinolic acid (Δ9-THCAA), and cannabidiolic acid (CBDA). Δ9-THCAA and CBDA are the natural precursors of Δ9-THC and CBD in the plant material. Decarboxylation to Δ9-THC and CBD is essential to get the total benefit of the neutral cannabinoids. Therefore, analysis for the neutral and acid cannabinoids is important to get a complete picture of the chemical profile of the products. The GC-MS method used for the analysis of these products was developed and validated. A 10-m × 0.18-mm DB-1 (0.4 μ film) column was used for the analysis. The majority of the hemp products were oils, while one of the products was hemp butter, one was a concentrated hemp powder capsule, and another was a hemp extract capsule. Most of the products contained less than 0.1% CBD and less than 0.01% Δ9-THC. Three products contained 0.1–1% CBD, and two products contained 0.1–0.9% Δ9-THC. All of the samples appeared to be decarboxylated since the CBDA and Δ9-THCAA results were less than 0.001%. The developed method is simple, sensitive, and reproducible for the detection of Δ9-THC, Δ9-THCAA, CBD, and CBDA in CBD/hemp oil products.

Introduction

References

Notes

This presentation is faithful to the original, with only a few minor changes to presentation. Some grammar, punctuation, and repetition was cleaned up in the title and text to improve readability. In some cases important information was missing from the references, and that information was added. Nothing else was changed in accordance with the NoDerivatives portion of the license.